We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Amazon.com, Bank of America, Roche, Oak Valley Bancorp and Ohio Valley Banc
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 9, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN - Free Report) , Bank of America Corp. (BAC - Free Report) , Roche Holding AG (RHHBY - Free Report) , Oak Valley Bancorp (OVLY - Free Report) and Ohio Valley Banc Corp. (OVBC - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Amazon, Bank of America & Roche
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN - Free Report) , Bank of America Corp. (BAC - Free Report) and Roche Holding AG (RHHBY - Free Report) , as well as two micro-cap stocks Oak Valley Bancorp (OVLY - Free Report) and Ohio Valley Banc Corp. (OVBC - Free Report) . The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
Amazon's shares have outperformed the Zacks Internet - Commerce industry over the past year (+13.8% vs. +3.8%). The company's international expansion and diversification across e-commerce, AWS cloud services, advertising, and streaming create multiple revenue streams while reducing concentration risk.
For 2Q'26, Amazon guided net sales of $194-$199 billion and operating income of $20-$24 billion. AI integration across operations enhances personalization, logistics, and AWS offerings, strengthening competitive positioning.
However, substantial capital expenditure requirements for AI infrastructure and data centers strain financial resources and compress margins, with trailing-12-month free cash flow decreasing to $1.2 billion. The company's expanding debt burden reduces financial flexibility amid rising interest rates. Intensifying competition from Walmart, Microsoft Azure, and Google Cloud is an overhang.
Shares of Bank of America have gained +23.7% over the past year against the Zacks Financial - Investment Bank industry's gain of +29.4%. The company's first-quarter 2026 results were aided by net interest income (NII) growth and strength in trading and investment banking (IB) businesses. Despite lower average rates, NII growth is expected to continue supported by steady loan growth and lower funding costs.
Bank of America's expansion strategy by opening financial branches in new and existing markets will boost the top line. Along with this, investments in digital capabilities will enhance client engagement and cross-selling opportunities, likely driving fee income.
However, the company's elevated expenses due to investments in technology and franchise expansion will likely hurt profits. The volatile nature of the capital markets business makes growth in trading revenues uncertain. Weak asset quality is another concern.
Roche's shares have gained +27.3% over the past year against the Zacks Large Cap Pharmaceuticals industry's gain of +27.7%. The company's sales in recent times have been weighed down by unfavorable foreign-exchange movements, the company's underlying operational performance remained solid. Strong growth from key products helps offset declining revenues from legacy drugs.
The stellar performances of multiple sclerosis drug Ocrevus and ophthalmology drug Vabysmo continue to drive momentum. Growth in hemophilia drug Hemlibra and breast cancer drug Phesgo also boosted the top line.
Roche is seeking to diversify its portfolio through acquisitions and collaborations as sales of legacy drugs, including Avastin, Herceptin, MabThera and Actemra, continue to decline due to biosimilar competition. The company is also expanding into high-growth markets such as obesity treatment. However, pipeline and regulatory setbacks continue to weigh on the stock.
Shares of Oak Valley have outperformed the Zacks Banks - West industry over the past year (+34.1% vs. +22.2%). This microcap company with a market capitalization of $287.82 million continues to improve profitability through net interest margin expansion, higher loan yields, and strong growth in non-interest income.
Oak Valley's well-established commercial banking franchise across California supports consistent loan growth opportunities, while disciplined underwriting and relationship-based lending have historically contributed to stable credit performance. It maintains a strong liquidity profile, with substantial cash and securities balances. Additionally, consistent earnings generation has strengthened capital levels.
On the downside, early signs of credit deterioration have emerged, including higher non-accrual and past-due loans, resulting in increased credit-loss provisions. The bank's significant concentration in commercial real estate (approximately 88% of loans) heightens sensitivity to weakening property markets. Valuation appears broadly in line with peers.
Ohio Valley Banc's shares have outperformed the Zacks Banks - Midwest industry over the past year (+59.1% vs. +5.1%). This microcap company with a market capitalization of $226.84 million has its investment thesis centered on its ability to drive sustainable earnings growth through disciplined balance-sheet management, a favorable shift toward higher-yielding loans and improving operating efficiency.
Expansion in core lending and a growing deposit base support recurring net interest income, while conservative capital management provides flexibility to fund growth and shareholder returns. The emphasis on secured, relationship-based lending enhances earnings quality.
However, rising credit costs, stress in select commercial relationships, funding competition and higher operating expenses remain key risks. Current valuation suggests investors already recognize OVBC's improving earnings profile and franchise strength, implying future upside will depend on continued execution, stable credit performance and sustained profitability across cycles.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
The Zacks Analyst Blog Highlights Amazon.com, Bank of America, Roche, Oak Valley Bancorp and Ohio Valley Banc
For Immediate Release
Chicago, IL – June 9, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN - Free Report) , Bank of America Corp. (BAC - Free Report) , Roche Holding AG (RHHBY - Free Report) , Oak Valley Bancorp (OVLY - Free Report) and Ohio Valley Banc Corp. (OVBC - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Amazon, Bank of America & Roche
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN - Free Report) , Bank of America Corp. (BAC - Free Report) and Roche Holding AG (RHHBY - Free Report) , as well as two micro-cap stocks Oak Valley Bancorp (OVLY - Free Report) and Ohio Valley Banc Corp. (OVBC - Free Report) . The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> New Inflation Numbers Out This Week: CPI, PPI
Today's Featured Research Reports
Amazon's shares have outperformed the Zacks Internet - Commerce industry over the past year (+13.8% vs. +3.8%). The company's international expansion and diversification across e-commerce, AWS cloud services, advertising, and streaming create multiple revenue streams while reducing concentration risk.
For 2Q'26, Amazon guided net sales of $194-$199 billion and operating income of $20-$24 billion. AI integration across operations enhances personalization, logistics, and AWS offerings, strengthening competitive positioning.
However, substantial capital expenditure requirements for AI infrastructure and data centers strain financial resources and compress margins, with trailing-12-month free cash flow decreasing to $1.2 billion. The company's expanding debt burden reduces financial flexibility amid rising interest rates. Intensifying competition from Walmart, Microsoft Azure, and Google Cloud is an overhang.
(You can read the full research report on Amazon here >>>)
Shares of Bank of America have gained +23.7% over the past year against the Zacks Financial - Investment Bank industry's gain of +29.4%. The company's first-quarter 2026 results were aided by net interest income (NII) growth and strength in trading and investment banking (IB) businesses. Despite lower average rates, NII growth is expected to continue supported by steady loan growth and lower funding costs.
Bank of America's expansion strategy by opening financial branches in new and existing markets will boost the top line. Along with this, investments in digital capabilities will enhance client engagement and cross-selling opportunities, likely driving fee income.
However, the company's elevated expenses due to investments in technology and franchise expansion will likely hurt profits. The volatile nature of the capital markets business makes growth in trading revenues uncertain. Weak asset quality is another concern.
(You can read the full research report on Bank of America here >>>)
Roche's shares have gained +27.3% over the past year against the Zacks Large Cap Pharmaceuticals industry's gain of +27.7%. The company's sales in recent times have been weighed down by unfavorable foreign-exchange movements, the company's underlying operational performance remained solid. Strong growth from key products helps offset declining revenues from legacy drugs.
The stellar performances of multiple sclerosis drug Ocrevus and ophthalmology drug Vabysmo continue to drive momentum. Growth in hemophilia drug Hemlibra and breast cancer drug Phesgo also boosted the top line.
Roche is seeking to diversify its portfolio through acquisitions and collaborations as sales of legacy drugs, including Avastin, Herceptin, MabThera and Actemra, continue to decline due to biosimilar competition. The company is also expanding into high-growth markets such as obesity treatment. However, pipeline and regulatory setbacks continue to weigh on the stock.
(You can read the full research report on Roche here >>>)
Shares of Oak Valley have outperformed the Zacks Banks - West industry over the past year (+34.1% vs. +22.2%). This microcap company with a market capitalization of $287.82 million continues to improve profitability through net interest margin expansion, higher loan yields, and strong growth in non-interest income.
Oak Valley's well-established commercial banking franchise across California supports consistent loan growth opportunities, while disciplined underwriting and relationship-based lending have historically contributed to stable credit performance. It maintains a strong liquidity profile, with substantial cash and securities balances. Additionally, consistent earnings generation has strengthened capital levels.
On the downside, early signs of credit deterioration have emerged, including higher non-accrual and past-due loans, resulting in increased credit-loss provisions. The bank's significant concentration in commercial real estate (approximately 88% of loans) heightens sensitivity to weakening property markets. Valuation appears broadly in line with peers.
(You can read the full research report on Oak Valley here >>>)
Ohio Valley Banc's shares have outperformed the Zacks Banks - Midwest industry over the past year (+59.1% vs. +5.1%). This microcap company with a market capitalization of $226.84 million has its investment thesis centered on its ability to drive sustainable earnings growth through disciplined balance-sheet management, a favorable shift toward higher-yielding loans and improving operating efficiency.
Expansion in core lending and a growing deposit base support recurring net interest income, while conservative capital management provides flexibility to fund growth and shareholder returns. The emphasis on secured, relationship-based lending enhances earnings quality.
However, rising credit costs, stress in select commercial relationships, funding competition and higher operating expenses remain key risks. Current valuation suggests investors already recognize OVBC's improving earnings profile and franchise strength, implying future upside will depend on continued execution, stable credit performance and sustained profitability across cycles.
(You can read the full research report on Ohio Valley Banc here >>>)
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Get all the details here >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.